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ABSTRACT
PURPOSE: To evaluate the changes in corneal transpar-
ency and thickness measured objectively using Penta-
cam Scheimpfl ug (Oculus Optikgeräte GmbH) corneal 
tomography (densitometry) after corneal cross-linking 
(CXL).
METHODS: Twenty-two eyes from 15 patients with 
keratoconus underwent CXL. Corneal thickness and cur-
vature as well as lens and corneal densitometry were 
measured at baseline and 1, 3, 6, and 12 months after 
CXL with Pentacam.
RESULTS: Immediately after CXL, central corneal thick-
ness signifi cantly decreased (240 µm) and corneal 
densitometry increased signifi cantly. At 6-month follow-
up, densitometry values were reduced and seemed to 
stabilize at a higher value than baseline. No statistically 
signifi cant differences were noted (mean difference at 
12 months: 130%). Changes in corneal densitometry 
were detected with the Pentacam even when clinical 
haze did not increase beyond grade 1 during follow-up.
CONCLUSIONS: Corneal CXL is associated with a tran-
sient reduction in central corneal thickness, which re-
covered to baseline after 12 months. During the same 
time period, corneal densitometry experienced a tran-
sient increase that recovered to baseline values after 3 
months. Changes in compactness of the corneal tissue 
after CXL may have an impact in corneal power not due 
to curvature changes, but to refractive index changes 
as a result of hydration changes. Pentacam is a useful 
objective method to monitor corneal transparency after 
CXL. [J Refract Surg. 2012;28(11):781-785.] 
doi:10.3928/1081597X-20121011-06
resently, corneal collagen cross-linking (CXL) with 
ribofl avin A is the only pharmacological treatment 
available for keratoconus.1 This treatment is intended 
to reinforce the corneal architecture by cross-linking 
the stromal lamellae in a transversal way.2 Several studies 
have proven that the treatment is safe, effective, and provides 
the desired stability of the condition3 as well as improves 
several topographic indices and visual acuity compared with 
untreated eyes.4 Despite this, the mechanism by which the 
anterior corneal surface changes towards a fl atter shape is not 
clear. Mechanical stretching of the corneal tissue could be 
related with the compaction of the collagen lamellae, thus 
thinning the cornea.5 However, it could also be argued that 
the entire cornea would stretch, thus exerting some backward 
movement that could be observed as a change in the posterior 
corneal surface and potentially on anterior chamber depth as 
measured with current Scheimpfl ug optical tomography.6
Transient corneal haze is a relatively common side effect 
of CXL and refl ects the healing process of the cornea.7-10 
Currently, haze can be measured objectively by optical 
methods such as Scheimpfl ug photography.11
The goal of this study was to objectively evaluate changes in 
central corneal thickness (CCT) and transparency after CXL 
in patients with keratoconus, as measured with Pentacam 
(Oculus Optikgeräte GmbH, Wetzlar, Germany).
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PATIENTS AND METHODS
Twenty-two eyes from 15 patients with keratoconus 
were evaluated with Pentacam. To minimize the effect 
of diurnal changes in corneal hydration, all measure-
ments were performed between 2:00 and 6:00 PM.12
Two days before treatment, patient eyelids were 
washed every 12 hours and a combination of dexametha-
sone and chloramphenicol was instilled three times a day.
Topical anesthesia of the cornea was obtained using 
oxybuprocaine and tetracaine drops, alternating every 
3 minutes for 9 minutes. During this time period, pilo-
carpine 2% eye drops were also instilled twice. After a 
lid speculum was inserted, a 9.0-mm diameter corneal 
abrasion was created. Ribofl avin 0.1% drops were in-
stilled every 3 minutes for 30 minutes. The ribofl avin 
drops were prepared immediately before treatment by 
mixing aqueous ribofl avin 0.5% solution with dextran 
T-500 20% solution. Central corneal pachymetry was 
performed using ultrasound. In eyes with a CCT (with-
out epithelium) ,400 µm, additional ribofl avin 0.1% 
drops without dextran (hypoosmotic drops) were ap-
plied until the thickness was .400 µm. The eyes were 
inspected at the slit-lamp to ensure that the ribofl avin 
had penetrated the aqueous (blue light). 
The eye was irradiated for 30 minutes with an ul-
traviolet-A irradiance of 3 mW/cm2 (UV-X; Peschke 
Meditrade GmbH, Hunenberg, Switzerland). During 
irradiation, the cornea was moistened every 5 min-
utes with ribofl avin 0.1% drops and oxybuprocaine 
drops every 10 minutes. Ofl oxacin 0.3% ointment was 
applied at the end of the procedure and the eye was 
patched. Patients were informed to use the tobramycin 
drops every 2 hours for 5 days. After epithelial healing, 
patients used topical fl uorometholone two times a day 
for 3 months. For eyes with sterile infi ltrates during the 
early postoperative period, dexamethasone drops were 
prescribed fi ve times a day for 1 week, after which the 
drops were tapered during the following 2 weeks. All 
procedures were uneventful. 
Statistical analysis was conducted with SPSS 18.0 
(SPSS Inc, Chicago, Illinois). Signifi cance of changes 
over time was assessed using analysis of variance after 
assessing normality in the data distribution with the 
Shapiro-Wilks W-test. Changes at subsequent follow-
up compared with baseline were assessed using paired 
sample t tests. P,.05 was considered statistically 
signifi cant.
RESULTS
Figure 1 is representative topographies before and 2 
months after CXL. Figure 2 shows changes in CCT over 
1 year of follow-up after CXL. A statistically signifi cant 
decrease was noted immediately after treatment (P,.01 
at 1 month and P,.05 at 3 and 6 months), returning to 
baseline values after 12 months (P..05). Figure 3 illus-
trates transient changes in corneal transparency show-
ing a signifi cant increase in corneal densitometry after 
1 month and remaining stable up to 3 months (P,.05 
against baseline) with reduction and stabilization of 
corneal transparency at 6 and 12 months postopera-
tively. These changes were present despite the absence 
of signifi cant haze observed on slit-lamp examination 
(no patient showed values over grade 1 on clinical ob-
servation).
Table A (available as supplemental material in 
the PDF version of this article) presents the changes 
in clinical and morphological corneal parameters 
showing mild changes in keratoconus indices over 
the course of follow-up. Index of vertical asymmetry 
(Fig 4) and index of height asymmetry (Fig 5) at 1 and 
3 months (P,.05 against baseline) returned to baseline 
values after 6 months.
Figure 1. Topographic images before (top) and 2 months after 
cross-linking treatment (bottom).
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DISCUSSION
Transient haze is a common side effect of corneal 
CXL. This reaction is related to the healing process after 
treatment and is commonly graded subjectively by slit-
lamp examination, which may not detect mild changes 
between follow-up visits. This is considered a transient 
consequence of the histological changes induced by the 
alteration of the cross-linked structure of the stroma, but 
defi nitive changes have also been documented.8 Haze 
formation is a concern after CXL, as it can potentially 
limit the benefi ts of the treatment by diminishing the 
transparency of the cornea, thus limiting the potential 
visual acuity achievable by means of subsequent treat-
ments13-15 or contact lens fi tting.16
This study demonstrates that Pentacam densitom-
etry measures are able to detect statistically signifi cant 
changes in corneal transparency 1 year after CXL in 
patients with keratoconus. The signifi cant increase 
and subsequent decrease in corneal densitometry after 
CXL in patients with keratoconus agrees with a study 
from Greenstein et al11 reporting the reduction of haze 
graded clinically with the slit-lamp from grade 0.78 to 
0.06 1 year after treatment. However, values observed 
in the present study are markedly higher despite pa-
tients not showing clinical haze over grade 1 on slit-
lamp examination.
It is well known that haze related with CXL is dif-
ferent from haze related with other treatments such 
as photorefractive keratectomy (PRK). Although PRK-
induced haze is limited to the subepithelial area, CXL-
related haze achieves up to 60% of the stromal depth. 
There have been several speculations regarding the 
etiology of haze in CXL and several studies have re-
lated it to loss of keratocytes.9 Other potential explana-
tions may relate this occurrence with the histological 
changes in terms of collagen structure. After CXL, the 
new molecular bridges established between collagen 
lamellae may affect the organization of the stromal 
structure responsible for corneal transparency. This 
effect is seen by evaluating the changes in corneal 
thickness immediately after treatment where marked 
thinning is present. Although haze and thinning are 
both related with the healing process and collagen re-
organization into the corneal stroma, the time period 
Figure 2. Change in central corneal thickness (CCT) measured at the 
geometric center with Pentacam.
Figure 3. Change in corneal and lens densitometry measured with 
Pentacam. P,.001 at 1 and 3 months compared to baseline for corneal 
densitometry and P=.014 between 1 and 3 months for lens densitometry.
Figure 4. Changes in Pentacam index of vertical asymmetry (IVA), kera-
toconus index (KI), and center keratoconus index (CKI).
Figure 5. Changes in Pentacam index of height asymmetry (IHA). 
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of change is markedly different, with corneal transpar-
ency recovering faster than corneal thickness.
The transient increase in some keratoconus indices 
is potentially related with the structural changes 
taking place within the cornea, which is refl ected in 
the present study by a transient statistically signifi -
cant increase in keratoconus grading and an increase 
in the index of height asymmetry; although this was 
not statistically signifi cant due to the higher variability 
in this parameter. The structural changes taking place 
after CXL may have signifi cant implications in terms 
of refraction mediated by the potential changes in the 
refractive index of the cornea.
Unless a loss of collagen lamellae could be demon-
strated, which is not likely as this will potentially re-
sult in weak corneal tissue after CXL for keratoconus, 
changes in corneal thickness seem to refl ect a compact-
ness of corneal stroma. We assume that keratocyte9 
and fundamental substance loss will result in a signifi -
cant loss of hydration and consequently a decrease in 
refractive index. A recent study has shown that CXL 
is related to increased keratocyte apoptosis, followed 
by a process of regeneration that may explain the tran-
sient haze noted after CXL.17 Another explanation of 
the thickness changes could be a misinterpretation of 
the anterior and posterior edges of the cornea by Penta-
cam as a result of the changes in induced transparency. 
However, in our patients, we ensured that all images 
were processed correctly and no misdetection of the 
posterior border occurred, thus we ruled out this po-
tential source of error for this sample. Moreover, other 
nonoptical techniques have obtained similar or higher 
thinning results. Holopainen and Krootila,5 using ul-
trasound pachymetry, observed an average thinning of 
87 µm just after treatment, which recovered to baseline 
after 6 months. It seems that the reduction in corneal 
thickness measured with ultrasound pachymetry fol-
lowing CXL may refl ect a true thinning effect of the 
treatment, thus supporting the Pentacam results.
Corneal thickness changes may be relevant in 
the understanding of the refractive changes in CXL. 
Assuming an increase in the compactness of the dry 
tissue, this will eventually result in an increase in the 
refractive index of the cornea. Leonard and Meek18 
obtained refractive indices of 1.411 and 1.365 for 
the fi brils and extrafi brillar material, respectively, in 
human corneal stroma and found that areas of more 
compactness, such as the center and anterior stroma,19 
have lower refractive index, likely due to a higher 
proportion of extrafi brillar material.20 This effect will 
be combined with the presence of a thinner corneal tis-
sue. However, a decrease in corneal thickness of 100 µm 
will have minor impact in the overall power of the 
cornea (,0.01 D). Changes in corneal hydration as a 
consequence of the CXL procedure could have greater 
refractive implications. Let us consider the known 
relationship between hydration and refractive index 
of hydrophilic soft materials (HEMA-based) as an ex-
ample to apply here. In this case, the refractive index 
of the cornea could change from 1.376 (assuming 78% 
corneal hydration or soft hydrogel Vasurfi lcon A with 
equilibrium water content of 74% and a refractive in-
dex of 1.379) to 1.415 (corresponding to Etafi lcon A 
material with 55% equilibrium water content assum-
ing that a 100-µm reduction in CCT will result in ap-
proximately 20% to 25% volume loss). This increase 
in refractive index will also increase the overall power 
of the cornea in the myopic direction by approximately 
6.00 to 7.00 D for a 6.5-mm corneal curvature in the 
anterior surface and 5.5-mm curvature in the posterior 
corneal surface (greater effect could be expected for 
steeper corneas). This effect needs to be verifi ed, but 
may limit the ability of CXL treatment in the earlier 
stages. In the long-term, a normalization of the hydra-
tion of the cornea and the fl attening effect induced 
by the corneal healing will result in better visual and 
refractive results or even in changes in the hyperopic 
direction when refractive index no longer plays a role 
and corneal fl attening induces a reduction in the myo-
pic power of the eye typical in patients with kerato-
conus. The same calculations for a reduction in CCT 
of 50 µm are in agreement with our results (reduction 
of approximately 10% to 15% in CCT resulting in a 
shift in refractive index from 1.376 to 1.39 typical of 
Alphafi lcon A material with 66% equilibrium water 
content), impacting the overall power of the cornea 
from 2.00 to 3.00 D in the myopic direction, which also 
agrees with results commonly found after CXL. The re-
fractive indices of hydrogel materials were considered 
from previously published results.21,22 Furthermore, 
changes in the refractive index of the cornea may in-
duce errors in keratometric and keratoscopic devices, 
but this is less likely considering that the detection of 
the anterior corneal surface (tear fi lm and epithelium) 
will not be affected by stromal hydration changes and 
healing processes subsequent to CXL treatment.
One limitation of the current study is that we do not 
know the actual value of the corneal thickness because 
only measurements with Pentacam were obtained. Due 
to the increased densitometry, the image quality of the 
optical sections obtained with the Pentacam may cre-
ate artifacts affecting the ability of the image analysis 
system to detect the edges of the cornea, thus report-
ing abnormal thickness values. However, the time pe-
riod of changes in thickness and keratoconus does not 
justify this behavior because even after the cornea has 
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recovered transparency, CCT did not recover to nor-
mal values. This is consistent with a previous report 
on transient thinning of the cornea with ultrasound 
pachymetry after CXL treatment.5
The slight reduction in lens densitometry seems to 
be related to the increasing absorption and diffusion of 
light by the cornea. In fact, there is not a cause for the 
transient increase in lens densitometry so this fi nding 
seems to be the result of an artifact due to increasing 
light absorption by the corneal tissue after CXL. Never-
theless, changes in lens densitometry were not statisti-
cally signifi cant during follow-up.
The present study demonstrates the impact of 
CXL in two fundamental properties of the corneal 
histology—CCT, which refl ects the compactness of 
the cornea after treatment, recovering to baseline val-
ues after 12 months, and transparency, which may re-
fl ect changes in the histological distribution of stromal 
lamellae that recovers 3 months after treatment. These 
changes in corneal compactness may be associated 
with the myopic transient effect found in patients after 
CXL. The automatic measure using Pentacam is able to 
detect subtle degrees of opalescence even in mild cases 
of haze as graded clinically through slit-lamp examina-
tion. Further improvements in the densitometry func-
tion, possibly measuring the entire area of increased 
density and integrating all density measures across 
the corneal volume, will make this objective measure 
more representative of the relevant clinical features.
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TABLE A
Parameters Evaluated After CXL in Patients With Keratoconus 
Parameter
Baseline
(n=22)
1 Month
(n=22)
3 Months 
(n=20)
6 Months 
(n=20)
12 Months 
(n=20) P Value*
Sphere (D) 22.9662.41 22.7860.26 22.6763.25 22.5863.33 22.6362.63 ..05
Cylinder (D) 2.9562.30 2.4562.20 3.4262.35 3.1962.13 3.2261.71 ..05
CDVA (decimal) 0.7060.26 0.7760.29 0.7360.19 0.7860.26 0.7960.25 ,.05
CCT (µm) 491641 438650† 445629† 455622† 489631   ,.001
Maximum anterior 
elevation (µm)
36617 40619 35616 32616 42623 ..05
Maximum posterior 
elevation (µm)
64629 70631 66624 68627 79637 ..05
Q (at 30°) (anterior) 20.6260.75 20.7860.91 20.9360.71 21.0260.73 20.5661.22 ..05
Q (at 30°) (posterior) 20.6960.60 20.9260.64 20.8060.63 20.7760.66 20.8960.63 ..05
ACD at center 
(mm)
3.3760.29 3.4460.31 3.4260.32 3.4060.32 3.4460.13 ..05
ACD at maximum 
posterior elevation 
(mm)
3.1760.28 3.1760.28 3.2460.33 3.2660.27 3.2960.27 ..05
AC volume (mm3) 207635 216635 211639 206640 205622 ..05
Grade of 
keratoconus
2.5760.88 2.7660.77† 2.6260.70 2.5060.71 2.5660.88 ,.05
ISV 99.05643.25 113.79646.34 102.89635.90 94.47633.07 105.11659.09 ..05
IVA 1.0960.59 1.2260.61 1.1260.53 1.0160.48 1.0560.85 ..05
KI 1.2760.17 1.3260.18 1.2860.15 1.2560.15 1.2860.22 ..05
CKI 1.0560.05 1.0860.06 1.0760.06 1.0660.06 1.0760.05 ..05
IHA 19.23619.12 22.21622.13 24.17621.60 19.83617.59 15.47617.55 ..05
IHD 0.0860.06 0.1060.07 0.0960.06 0.0760.06 0.0760.06 ..05
Rmin (mm) 5.9560.72 5.7360.74 5.8360.71 5.9860.72 5.8360.77 ..05
CDVA = corrected distance visual acuity, CCT = central corneal thickness, Q = asphericity, ACD = anterior chamber depth, AC = anterior chamber, ISV = index 
of surface variance, IVA = index of vertical asymmetry, KI = keratoconus index, CKI = center keratoconus index, IHA = index of height asymmetry, IHD = index of 
height decentration, Rmin = minimum sagittal curvature
*Analysis of variance.
†Statistically significant compared to baseline.
Keratoconus grading was performed automatically according to the Pentacam software.
